Welcome to our dedicated page for Inmode Ltd. news (Ticker: INMD), a resource for investors and traders seeking the latest updates and insights on Inmode Ltd. stock.
News about InMode Ltd. (INMD) centers on its role as a global provider of medical technologies based on novel radio frequency (RF) energy, along with its financial performance as a Nasdaq-listed company. Press releases regularly highlight quarterly and annual results, revenue guidance ranges, and commentary from management on market conditions, tariffs, and geopolitical developments affecting its operating environment.
Investors following InMode news will find detailed updates on quarterly revenues, gross margins, operating income, and cash position, often presented alongside non-GAAP metrics that exclude share-based compensation and related tax adjustments. The company also issues announcements when it provides or revises full-year revenue guidance, giving insight into management’s expectations for its RF-based aesthetic and medical device business.
Another key news theme is capital markets and investor relations activity. InMode frequently announces participation in major healthcare and medical technology investor conferences hosted by firms such as UBS, Jefferies, Canaccord Genuity, Baird, and Needham. These items describe fireside chats, formal presentations, and one-on-one investor meetings featuring senior executives, as well as links to live webcasts and replays.
Corporate governance and shareholder matters also appear in the news flow. For example, an external stockholder, DOMA Perpetual Capital Management LLC, publicly released a letter urging InMode’s board to expand capital returns to shareholders, focusing on share repurchases and discussing the company’s cash position and valuation. In addition, InMode has announced leadership changes, such as the appointment of a President of North America, reflecting developments in its organizational structure and regional strategy.
By tracking INMD news, readers can monitor earnings releases, guidance updates, conference participation, shareholder communications, and leadership announcements that together provide a current picture of how InMode presents its business and responds to financial and market dynamics.
InMode (Nasdaq: INMD) will present at two investor conferences in March 2026: Barclays 28th Annual Global Healthcare Conference and Oppenheimer 36th Annual Healthcare MedTech & Services Conference.
Presenters: Yair Malca, CFO (Barclays); Moshe Mizrahy, CEO, and Yair Malca, CFO (Oppenheimer). Webcasts are scheduled for March 11 and March 16.
InMode (Nasdaq: INMD) announced that its Board's independent transaction committee has completed a review of proposals for a potential transaction and determined that none of the final proposals was adequate or in shareholders' best interests.
The Committee has discontinued the process; the company will continue to evaluate business and cash allocation strategies to enhance long-term shareholder value and does not intend further updates unless appropriate or required.
InMode (Nasdaq: INMD) reported Q4 2025 GAAP revenue of $103.9 million (+6% vs. Q4 2024) and full‑year 2025 revenue of $370.5 million (‑6% vs. 2024). GAAP net income was $27.0M in Q4 and $93.8M for FY 2025. Cash and marketable securities totaled $555.3M at year‑end. The company repurchased $127.4M of shares in 2025. Management expects 2026 revenue of $365M–$375M and non‑GAAP diluted EPS of $1.43–$1.48. Non‑GAAP measures exclude share‑based compensation and tax benefit adjustments.
InMode (Nasdaq: INMD) will participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT. Yair Malca, Chief Financial Officer, will host investor meetings on Wednesday, February 11, 2026. Interested investors should contact their BTIG salesperson to schedule a meeting and may visit InMode's investor relations site for event details.
InMode (NASDAQ: INMD) said it is aware of market speculation, including a non-binding proposal by Steel Partners to acquire 51% of outstanding shares, and confirmed it is evaluating strategic alternatives.
The company formed an independent directors' committee, retained independent legal and financial advisors, and said there is no assurance a transaction will occur or on timing or terms.
Steel Partners Holdings offered to buy 51% of InMode (NASDAQ: INMD) at $18.00 per share, a 29% premium to the unaffected January 23, 2026 price. Steel says the offer is fully funded with no financing contingency and cites weak TSR, high cash balances, and repeated guidance cuts.
InMode (Nasdaq: INMD) expects to release fourth-quarter and full-year 2025 results before market open on February 10, 2026 and will hold a conference call the same day at 8:30 a.m. ET. Management provided preliminary, subject-to-adjustment ranges: Q4 2025 revenue $103.6M–$103.8M; FY2025 revenue $370.2M–$370.4M; FY2025 non-GAAP gross margin 78%–79%. The company also provided FY2026 revenue guidance $365M–$375M. Speakers will include CEO Moshe Mizrahy, CFO Yair Malca and CTO Michael Kreindel. A live webcast and replay will be available; preregistration is offered for dial-in access.
InMode (NASDAQ: INMD) reported Q3 2025 GAAP revenue of $93.2M, down from $130.2M in Q3 2024 (which included $31.9M of pre-order sales). GAAP and non-GAAP gross margin was 78%. GAAP net income was $21.9M ($0.34 diluted EPS) and non-GAAP net income was $24.5M ($0.38 diluted EPS). Cash and marketable securities totaled $532.3M as of September 30, 2025. Management reaffirmed full‑year 2025 guidance: revenues of $365M–$375M, non‑GAAP gross margin 78%–80%, non‑GAAP operating income $93M–$98M, and non‑GAAP EPS $1.55–$1.59. Company noted cautious consumer demand and named Michael Dennison president of North America.
InMode (Nasdaq: INMD) appointed Michael Dennison as President of North America, effective Nov. 3, 2025. Dennison joins the role after nearly a decade at InMode and promotion from Vice President of Sales. The company said he progressed through roles from District Sales Manager to VP of Sales, driving national revenue growth, expanding market share, and strengthening distribution across North America.
Management said the move is part of a North American restructuring intended to advance strategic initiatives and accelerate growth. Dennison previously held multiple leadership positions at Cynosure and is described as having consistently exceeded sales targets and built high-performing teams.
InMode (Nasdaq: INMD) will participate in three investor conferences in November 2025: the UBS Global Healthcare Conference (in-person one-on-ones, Palm Beach Gardens, FL) on Monday, November 10; the Jefferies Global Healthcare Conference (in-person fireside chat and one-on-ones, London, U.K.) with a fireside chat at 4:00 pm GMT on Tuesday, November 18 and a live webcast available; and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (in-person one-on-ones, New York, NY) on Thursday, November 20. Presenters include CEO Moshe Mizrahy and CFO Yair Malca.